Antara News·Indonesia·Thursday, October 29, 2026 at 11:55 AM UTC

Indonesia preparing to extend HPV vaccination to young adults in 2027

Translate

Mecca Yumna, Raka Adji

Jakarta (ANTARA) - Indonesia's Health Ministry is preparing to expand its human papillomavirus (HPV) vaccination program to adults ages 21 and 22 in 2027, pending approval and logistical preparations, an official said.

Indri Yogyaswari, the ministry's immunization director, said the ministry was coordinating with the National Development Planning Agency (Bappenas) on vaccine supplies, logistics and staffing.

"If everything goes smoothly and the plan is approved by the Finance Ministry and Bappenas, we will target older age groups next year," she said here Thursday.

Unlike its HPV vaccination program for children, the ministry has no established best-practice model for vaccinating adults, she said.

The ministry plans to distribute vaccines through local health offices, community health centers (puskesmas) and integrated health posts (posyandu), but adult vaccinations will not be covered by national health insurer BPJS Kesehatan.

According to ministry data, private clinics charge Rp1.2 million (about US$66) to Rp1.5 million (about US$83) per dose, and adults need two to three doses.

"We still need to finalize the strategy," Indri said.

She said an evaluation found global immunization rates were declining, partly because of concerns about adverse events following immunization and false claims that HPV vaccines cause infertility or autism.

Hindra Irawan Satari of Indonesia's National Committee for Adverse Events Following Immunization said HPV shots are best given at ages 9-12. Cervical cancer may remain symptom-free for 15-20 years and be found at stage 3.

View the original on Antara News →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.